trending Market Intelligence /marketintelligence/en/news-insights/trending/i-kz2t_5k997yy01wrmoya2 content esgSubNav
In This List

Medovex COO resigns

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Medovex COO resigns

Medovex Corp. said Patrick Kullman resigned as COO, effective Feb. 2.

Kullman's resignation was not a result of or caused by any disagreement with Medovex.

Medovex entered into a consulting agreement with Kullman through his company, CG3 Consulting LLC, effective Feb. 16, under which Kullman agreed to provide certain consulting services to the company.